Pages that link to "Q41976375"
Jump to navigation
Jump to search
The following pages link to Observations on the prophylaxis of experimental pulmonary anthrax in the monkey (Q41976375):
Displaying 50 items.
- Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax (Q24546050) (← links)
- Anthrax in America 2001-2003 (Q24650441) (← links)
- Anthrax vaccine design: strategies to achieve comprehensive protection against spore, bacillus, and toxin (Q24796044) (← links)
- Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001 (Q26154903) (← links)
- Quantitative models of the dose-response and time course of inhalational anthrax in humans (Q27333946) (← links)
- Alternative pre-approved and novel therapies for the treatment of anthrax (Q28075453) (← links)
- Quantitative pathology of inhalational anthrax I: quantitative microscopic findings (Q28189054) (← links)
- Protective antigen and toxin neutralization antibody patterns in anthrax vaccinees undergoing serial plasmapheresis. (Q28384322) (← links)
- Inhalational anthrax (Ames aerosol) in naïve and vaccinated New Zealand rabbits: characterizing the spread of bacteria from lung deposition to bacteremia (Q28387410) (← links)
- Anthrax vaccination strategies (Q28392248) (← links)
- Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits (Q28394063) (← links)
- Pediatric anthrax clinical management (Q28397091) (← links)
- Rabbit and nonhuman primate models of toxin-targeting human anthrax vaccines (Q28398013) (← links)
- Sverdlovsk revisited: modeling human inhalation anthrax (Q28767847) (← links)
- Evaluation of early immune response-survival relationship in cynomolgus macaques after Anthrax Vaccine Adsorbed vaccination and Bacillus anthracis spore challenge (Q30152051) (← links)
- Updating Perspectives on the Initiation of Bacillus anthracis Growth and Dissemination through Its Host (Q30424243) (← links)
- Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers. (Q32061006) (← links)
- Primary involvement of pharynx and peyer's patch in inhalational and intestinal anthrax (Q33286415) (← links)
- Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax (Q33396429) (← links)
- Anthrax prevention and treatment: utility of therapy combining antibiotic plus vaccine (Q33505445) (← links)
- Bacillus anthracis spore entry into epithelial cells is an actin-dependent process requiring c-Src and PI3K. (Q33638446) (← links)
- Bacillus anthracis: medical issues of biologic warfare (Q33677543) (← links)
- A Bayesian approach for estimating bioterror attacks from patient data (Q33724406) (← links)
- Capsule synthesis by Bacillus anthracis is required for dissemination in murine inhalation anthrax (Q33739694) (← links)
- Combining anthrax vaccine and therapy: a dominant-negative inhibitor of anthrax toxin is also a potent and safe immunogen for vaccines (Q33788263) (← links)
- Bacillus anthracis spore interactions with mammalian cells: relationship between germination state and the outcome of in vitro (Q33831092) (← links)
- Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence (Q33962064) (← links)
- Efficiency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization (Q34117219) (← links)
- Postexposure prophylaxis against anthrax: evaluation of various treatment regimens in intranasally infected guinea pigs (Q34182441) (← links)
- Combination therapy with antibiotics and anthrax immune globulin intravenous (AIGIV) is potentially more effective than antibiotics alone in rabbit model of inhalational anthrax (Q34194627) (← links)
- Development of a highly efficacious vaccinia-based dual vaccine against smallpox and anthrax, two important bioterror entities (Q34241550) (← links)
- Recombinant Protective Antigen Anthrax Vaccine Improves Survival when Administered as a Postexposure Prophylaxis Countermeasure with Antibiotic in the New Zealand White Rabbit Model of Inhalation Anthrax (Q34303179) (← links)
- An anthrax subunit vaccine candidate based on protective regions of Bacillus anthracis protective antigen and lethal factor. (Q34433313) (← links)
- Cathelicidin administration protects mice from Bacillus anthracis spore challenge (Q34476038) (← links)
- Immunogenicity and safety of four different dosing regimens of anthrax vaccine adsorbed for post-exposure prophylaxis for anthrax in adults (Q34602462) (← links)
- Threats in bioterrorism. I: CDC category A agents (Q34743491) (← links)
- Characterization of Bacillus anthracis persistence in vivo (Q34764384) (← links)
- The prophylaxis and treatment of anthrax (Q34997152) (← links)
- Pharmacokinetic considerations and efficacy of levofloxacin in an inhalational anthrax (postexposure) rhesus monkey model (Q35127882) (← links)
- Prevention and treatment of bacterial diseases caused by bacterial bioterrorism threat agents (Q35557394) (← links)
- Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs (Q35560377) (← links)
- Anthrax vaccine: a review (Q35643939) (← links)
- Modeling the optimum duration of antibiotic prophylaxis in an anthrax outbreak (Q35812522) (← links)
- Death at Sverdlovsk: what have we learned? (Q35834195) (← links)
- US Food and Drug Administration approval of ciprofloxacin hydrochloride for management of postexposure inhalational anthrax (Q35861305) (← links)
- Cost-effectiveness comparison of response strategies to a large-scale anthrax attack on the chicago metropolitan area: impact of timing and surge capacity (Q36229010) (← links)
- ON THE RECOGNITION AND THERAPY OF SIMIAN WOOLSORTER'S DISEASE. (Q36258885) (← links)
- Parenteral Administration of Capsule Depolymerase EnvD Prevents Lethal Inhalation Anthrax Infection (Q36290799) (← links)
- The Exosporium Layer of Bacterial Spores: a Connection to the Environment and the Infected Host (Q36294717) (← links)
- Development of an inhalational Bacillus anthracis exposure therapeutic model in cynomolgus macaques (Q36378610) (← links)